descartes-08
descartes-08: developed by 1 company · 1 clinical trial tracked · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | Phase 3 |
Clinical Trials (1)
Descartes-08 for Patients With Systemic Lupus Erythematosus
FDA Decisions
FDA_MeetingThe Company received written agreement from the FDA under the Special Protocol Assessment process on the overall design of the Phase 3 AURORA trial for Descartes-08 in myasthenia gravis.(RNAC)
Frequently asked questions
Who is developing descartes-08?
descartes-08 is being developed by Cartesian Therapeutics, Inc..
How many clinical trials involve descartes-08?
BioSniper tracks 1 clinical trial involving descartes-08.
What is descartes-08's latest FDA decision?
The most recent tracked FDA decision for descartes-08 is FDA_Meeting for The Company received written agreement from the FDA under the Special Protocol Assessment process on the overall design of the Phase 3 AURORA trial for Descartes-08 in myasthenia gravis., dated January 27, 2025.
Get deeper analysis on descartes-08
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis